ID: ALA145341

Max Phase: Preclinical

Molecular Formula: C19H21NO2

Molecular Weight: 295.38

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCc1ccc(C(=O)NC(C)(C)C(=O)c2ccccc2)cc1

Standard InChI:  InChI=1S/C19H21NO2/c1-4-14-10-12-16(13-11-14)18(22)20-19(2,3)17(21)15-8-6-5-7-9-15/h5-13H,4H2,1-3H3,(H,20,22)

Standard InChI Key:  YLERBDLEVOSOAZ-UHFFFAOYSA-N

Associated Targets(non-human)

Ecdysone receptor 281 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 295.38Molecular Weight (Monoisotopic): 295.1572AlogP: 3.64#Rotatable Bonds: 5
Polar Surface Area: 46.17Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 4.24CX LogD: 4.24
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.86Np Likeness Score: -0.84

References

1. Tice CM, Hormann RE, Thompson CS, Friz JL, Cavanaugh CK, Michelotti EL, Garcia J, Nicolas E, Albericio F..  (2003)  Synthesis and SAR of alpha-acylaminoketone ligands for control of gene expression.,  13  (3): [PMID:12565954] [10.1016/s0960-894x(02)00980-0]

Source